Back to Search
DHWANIL VYAS, M.D.
M.D.
Internal Medicine Physician
NPI: 1295043388IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology Physician
Internal Medicine — Nephrology
Code: 207RN0300X
125364(CA)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
125364(CA)
Education
OTHER
Class of 2012
Research & Publications (20)
Conservative management of a three-day-old esophageal perforation with feeding jejunostomy and prokinetic drug.
PMID 16990212·Scand J Gastroenterol·2006
5-case
Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.
PMID 15947070·Am J Physiol Regul Integr Comp Physiol·2005
4-observational
GSK-3beta negatively regulates skeletal myotube hypertrophy.
PMID 12107064·Am J Physiol Cell Physiol·2002
7-preclinical
Eye conditions among 5- to 7-year-old Asian-Pacific Islander schoolchildren in Southern California.
PMID 11486937·Optometry·2001
8-other
Multiprotein complex formation at the beta myosin heavy chain distal muscle CAT element correlates with slow muscle expression but not mechanical overload responsiveness.
PMID 11010974·J Biol Chem·2001
7-preclinical
Azocalix[4]pyrrole Amberlite XAD-2: new polymeric chelating resins for the extraction, preconcentration and sequential separation of Cu(II), Zn(II) and Cd(II) in natural water samples.
PMID 19635367·Talanta·2009
8-other
Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors.
PMID 18572407·Bioorg Med Chem Lett·2008
8-other
Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one (BMS-695735), an orally efficacious inhibitor of insulin-like growth factor-1 receptor kinase with broad spectrum in vivo antitumor activity.
PMID 18763755·J Med Chem·2008
7-preclinical
Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis.
PMID 17998890·Shock·2008
7-preclinical
2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924.
PMID 18258427·Bioorg Med Chem Lett·2008
7-preclinical
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17606372·Bioorg Med Chem Lett·2007
7-preclinical
Plants at high altitude exhibit higher component of alternative respiration.
PMID 16338027·J Plant Physiol·2007
4-observational
Tea (Camellia sinensis) clones with shorter periods of winter dormancy exhibit lower accumulation of reactive oxygen species.
PMID 17545125·Tree Physiol·2007
8-other
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
PMID 17540562·Bioorg Med Chem Lett·2007
7-preclinical
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17368025·Bioorg Med Chem Lett·2007
7-preclinical
Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase.
PMID 17187980·Bioorg Med Chem Lett·2007
7-preclinical
Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile.
PMID 17398093·Bioorg Med Chem Lett·2007
7-preclinical
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
PMID 17270437·Bioorg Med Chem Lett·2007
7-preclinical
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
PMID 17317169·Bioorg Med Chem Lett·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 9350 CAMPUS POINT DR
LA JOLLA, CA 92037 - Phone
- (800) 926-8273
Quick Facts
- NPI
- 1295043388
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile